<?xml version='1.0' encoding='utf-8'?>
<document id="25210009"><sentence text="Effects of a computerized decision support system in improving pharmacological management in high-risk cardiovascular patients: A cluster-randomized open-label controlled trial." /><sentence text="This study was aimed to investigate the effects of computerized decision support system in improving the prescription of drugs for cardiovascular prevention" /><sentence text=" A total of 197 Italian general practitioners were randomly allocated to receive either the alerting computerized decision support system integrated into standard software (intervention arm) or the standard software alone (control arm)" /><sentence text=" Data on 21230 patients with diabetes, 3956 with acute myocardial infarction, and 2158 with stroke were analysed" /><sentence text=" The proportion of patients prescribed with cardiovascular drugs and days of drug-drug interaction exposure were evaluated" /><sentence text=" Computerized decision support system significantly increased the proportion of patients with diabetes prescribed with antiplatelet drugs (intervention: +2" /><sentence text="7% vs" /><sentence text="" /><sentence text="+0" /><sentence text="15%; p &lt; 0" /><sentence text="001) or lipidlowering drugs (+4" /><sentence text="2% vs" /><sentence text=" +2" /><sentence text="8%; p = 0" /><sentence text="001)" /><sentence text=" A statistically significant decrease in days of potential interactions has been observed only among patients with stroke (-1" /><sentence text="2 vs" /><sentence text=" -0" /><sentence text="5 days/person-year; p = 0" /><sentence text="001)" /><sentence text=" In conclusion, computerized decision support system significantly increased the use of recommended cardiovascular drugs in diabetic patients, but it did not influence the exposure to potential interactions" /><sentence text="" /></document>